VNDA
Vanda Pharmaceuticals Inc. · Healthcare
SVP, Business Development Gunther Birznieks sold $73K of Vanda Pharmaceuticals Inc.
Sold$73,379
$4.21Price
17,411Shares
−5%Stake
What VNDA did after the filing
- The stock from Wed, Mar 6 close, $3.91
- +27.1%
- S&P 500, same days
- −1.7%
Measured over 30 trading days, to the Apr 18 close.
Traded Mon, Mar 4. Filed Wed, Mar 6, 11:46 AM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.